AbbVie Acquires ImmunoGen, for Approx. $10.1 Billion
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
Page 3 - Mark Enyedy News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Mark Enyedy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Mark Enyedy Today - Breaking & Trending Today
ImmunoGen, Inc. (NASDAQ:IMGN) Q3 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to ImmunoGen's Third Quarter 2023 Financial and Operating Results Conference Call. Today's conference is being recorded.
Source: insidermonkey.com
Immunogen Inc (IMGN) Reports Q3 2023 Earnings: Net Income of $30.7 Million
ELAHERE's Strong Demand Drives Revenue Growth
Source: yahoo.com
ImmunoGen Appoints Lauren White as Senior Vice President and Chief Financial Officer
ImmunoGen, Inc. , a leader in the expanding field of antibody-drug conjugates for the treatment of cancer, today announced that Lauren White has been appointed Senior Vice President and Chief...
Source: marketscreener.com
ImmunoGen Inks Pact With Takeda To Develop ELAHERE Ovarian Cancer Drug In Japan - Immunogen (NASDAQ:IMGN), Takeda Pharmaceutical (NYSE:TAK)
ImmunoGen, Inc. (NASDAQ: IMGN) inked pacts with Takeda Pharmaceutical Company Limited (NYSE: TAK) to develop and
Source: benzinga.com